Drug
TQB3454 tablets
TQB3454 tablets is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
1
25%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Other(2)
Detailed Status
unknown2
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
Trials by Status
not_yet_recruiting125%
unknown250%
active_not_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
NCT07738679
active_not_recruitingphase_3
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT05987358
unknownphase_1
A Study of TQB3454 Tablets in Patients With Blood Tumors
NCT06218771
unknownphase_1
A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
NCT06139367
Clinical Trials (4)
Showing 4 of 4 trials
NCT07738679Phase 2
Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid Tumors
NCT05987358Phase 3
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
NCT06218771Phase 1
A Study of TQB3454 Tablets in Patients With Blood Tumors
NCT06139367Phase 1
A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4